WJCD  Vol.5 No.8 , August 2015
Prognostic Role of Pulse Pressure in the Acute Phase of Myocardial Infarction
Objective: Pulse pressure is a cardiovascular risk factor. The aim of our study was to assess the short and medium term prognosis of myocardial infarction in the African black having a high pulse pressure. Methods: We performed a comparative retrospective study of 200 patients hospitalized in the Cardiology Institute of Abidjan. The first group (100 patients) had a high pulse pressure (≥60 mmHg). The second (100 patients) had normal pulse pressure (≤60 mmHg). The primary outcome was mortality. Secondary endpoints were represented by hemodynamic complications, rhythmic and conduction disturbances. Both groups of patients were matched. The matching is performed by socio-demographic criteria, the seat of necrosis and cardiovascular risk factors. The authors explained the choice of 60 mmHg as references because in all their studies they have realized that it is from 60 mmHg pulse pressure morbid events that occur in prospective studies and retrospective studies in stiffness of the great arteries is responsible for all these events. Pulse pressure is in itself, an independent cardiovascular risk factor in systolic blood pressure, diastolic blood pressure when associated with myocardial infarction, it becomes from 60 mmHg poor prognostic factor especially in the acute phase. Results: The mean age was 54.46 ± 10.10 years for patients with normal pulse pressure and 52.32 ± 10.89 years in patients with high pulse pressure. Patients with elevated pulse pressure were twice as left ventricular failure (Chi2 = 3.71; P = 0.048 = 2 OR 95% CI = 0.93 to 4.29). These patients had an ejection fraction and fractional shortening double bass (Chi2 = 31.23 P = 0.00001, OR = 2.2 95% CI 0.8 to 17.4) 10 mmHg for increased pulse pressure we observed an average growth of 18% mortality rate. Mortality was three times higher in patients with elevated pulse pressure (Khi2 = 15, 06 ddl = 1 P = 0.0001 OR = 3.34 95% CI 1.72 to 6.52). Conclusion: The high pulse pressure represented an independent poor prognostic factor in the acute phase of myocardial infarction in the black African.

Cite this paper
Koffi, J. , Konin, C. , N’goran, Y. , Ekou, A. , Gnaba, A. , Soya, E. , Mottoh, M. , Boka, B. and Adoh, M. (2015) Prognostic Role of Pulse Pressure in the Acute Phase of Myocardial Infarction. World Journal of Cardiovascular Diseases, 5, 254-260. doi: 10.4236/wjcd.2015.58028.
[1]   Guideline Subcommittee (1999) Word Heath Organization—International Society of Hypertension Guideline for the Management of Hypertension. Journal of Hypertension, 17, 151-183.

[2]   Joint National Committee on Detection (1997) Evaluation and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention and Treatment of High Blood Pressure (JNC VI). Archives of Internal Medicine, 157, 2413-2446.

[3]   Safar, M.E. and London, G.M. (1994) The Arterial System in Human Hypertension. In: Swales, J.D., Ed., Textbook of Hypertension, Blackwell Sc, London, 85-102.

[4]   Nichols, W.W. and O’Rourke, M. (1998) McDonald’s Blood Flow in Arteries. Theoretical, Experimental and Clinical Principle. 4th Edition, Arnold E., London, 54-113, 201-222, 284-292, 347-401.

[5]   Darne, B., Girerd, X., Safar, M., Cambien, F. and Guize, L. (1989) Pulsatile versus Steady Component of Blood Pressure: A Cross-Sectional Analysis and a Prospective Analysis on Cardiovascular Mortality. Hypertension, 13, 392-400.

[6]   Danchin, N. (2002) Pulse Pressure and Coronary Disease. Archives of Disease and Vascular, 95, 7-10.

[7]   Benetos, A., Rudnich, A., Safar, M. and Guize, L. (1998) Pulse Pressure and Cardiovascular Mortality in Normotensive and Hypertensive Subjects. Hypertension, 32, 560-564.

[8]   Mitchell, G.F., Moye, L.M., Braunwald, E., Rouleau, J.L., Bernstein, V., Geltman, E.M., Flaker, G.C. and Pfeffer, M.A. (1997) For the Save Investigators. Sphygmomanometrically Determined Pulse Pressure Is a Powerful Independent Predictor of Recurrent Events after Myocardial Infarction in Patients with Impaired Left Ventricular Function. Circulation, 96, 4254-4260.

[9]   Black, H.R. (1999) Paradigm Has Shifted, to Systolic Blood Pressure. Hypertension, 34, 386-387.

[10]   Giovanni, D.S., Mary, J., Michael, H. and Alderman Mauzizo, G.D.D. (2005) Is High Pulse Pressure a Marker of Preclinical Cardiovascular Disease? Hypertension, 45, 575-579.

[11]   Grossman, W. (2000) Defining Diastolic Dysfunction. Circulation, 101, 2020-2021.

[12]   Schram, M.T., Kostense, P.J., Van Dijk, R.A., Dekker, J.M., Nijpels, G. and Boutier, L.M. (2002) Diabetes, Pulse Pressure and Cardiovascular Mortality: The Hoorn Study. Journal of Hypertension, 20, 1743-1751.

[13]   Black, H.R. and Yi, J.Y. (1996) A New Classification for Hypertension Based on Relative and Absolute Risk with Implications for Treatment and Reimbursement Hypertension. Hypertension, 28, 719-724.

[14]   Vasan, R.S. and Larson, M.G. (1999) Congestive Heart Failure in Subjects with Normal versus Reduced Left Ventri cular Ejection Fraction. Journal of the American College of Cardiology, 3, 1948-1955.

[15]   Sagie, A., Larson, M.G. and Levy, D. (1993) The Natural History of Borderline Isolated Systolic Hypertension. New England Journal of Medicine, 329, 1912-1917.

[16]   Warner, J.G., Metzger, C., Kitzman, D.W., Wesley, D.J. and Little, W.C. (1999) Losartan Improves Exercise Tolerance in Patients with Diastolic Dysfunction and a Hypertensive Response to Exercise. Journal of the American College of Cardiology, 33, 1567-1572.

[17]   Madhavan, S., Ooi, W.L., Cohen, H. and Alderman, M.H. (1994) Relation of Pulse Pressure and Blood Pressure Reduction to the Incidence of Myocardial Infarction. Hypertension, 23, 395-401.

[18]   Chae, C.U., Pfeffer, M.A., Glynn, R.J., Mitchel, G.F., Taylor, J.O. and Hennkens, C.H. (1999) Increased Pulse Pressure and Risk of Heart Failure in the Elderly. JAMA, 281, 634-643.

[19]   Vaccarino, V., Holford, T.R. and Krumhomlz, H.M. (2000) Pulse Pressure and Risk of Myocardial Infarction and Heart Failure in the Elderly. Journal of the American College of Cardiology, 36, 130-138.

[20]   Pernenkil, R., Vinson, J.M., Shah, A.S., Beckham, V., Wittenbertg, C. and Rich, M.W. (1997) Course and Prognosis in Patients Superior 70 Years of Age with Congestive Heart Failure and Normal versus Abnormal Left Ventricular Ejection Fraction. The American Journal of Cardiology, 79, 216-219.

[21]   Domanski, M.J., Sutton-Tyrrell, K., Mitchell, G.F., Faxon, D.P., Pitt, B. and Sopko, G. (2001) Determinants and Prognostic Information Provided by Pulse Pressure in Patients with Coronary Artery Disease Undergoing Revascularization (The Balloon Angioplasty Revascularization Investigation). The American Journal of Cardiology, 87, 675-679.

[22]   Saeed, M. and Wilson, M.W. (2014) Monitoring the Sequelae of Coronary Microembolization on Myocardium Using Noninvasive Imaging (Review). World Journal of Cardiovascular Diseases, 4, 601-622.

[23]   Konin, C., Adoh, A.M., Diby, F., Koffi, J. and N’Guetta, R. (2008) Epidemiological and Etiological Profile of Myocardial Infarction Deaths in Abidjan. African Journal of Medicine, 55, 8-9.

[24]   Abed, Y. and Jamee, A. (2015) Characteristics and Risk Factors Attributed to Coronary Artery Disease in Women Attended Health Services in Gaza-Palestine Observational Study. World Journal of Cardiovascular Diseases, 5, 9-18.

[25]   Bouraoui, H., Trimche, B. and Ernez-Hajri, S. (2005) Impact of Diabetes on the Prognosis of Myocardial Infarction. Annales de Cardiologie et d’Angéiologie, 54, 55-59.